GlassScriptPhysician profile
Humberto Jose Caldera
NPI 1891749164
$67,075.74
in general payments reported to CMS, 2019-2025
87 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $8,180 · 2021: $6,451 · 2022: $8,005 · 2023: $4,459 · 2024: $8,116 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Consulting Fee: $11K · Honoraria: $1,500 · Travel and Lodging: $1,451 · Education: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,963.30 |
| Consulting Fee | $10,991.00 |
| Honoraria | $1,500.00 |
| Travel and Lodging | $1,451.14 |
| Education | $576.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15,690.56 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Astrazeneca Pharmaceuticals LP | $9,708.63 | 2019-2025 | Imfinzi, Enhertu, Tagrisso |
| Incyte Corporation | $4,716.55 | 2019-2025 | Jakafi |
| Pfizer INC. | $3,608.90 | 2019-2025 | |
| Beigene USA, INC. | $3,516.92 | 2020-2025 | Brukinsa |
| Janssen Biotech, INC. | $3,408.29 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Seagen INC. | $2,106.62 | 2019-2025 | Tukysa, Tivdak |
| Pharmacosmos Therapeutics INC. | $1,799.49 | 2022-2024 | Monoferric |
| Puma Biotechnology, INC. | $1,637.90 | 2019-2025 | Nerlynx |
| Bayer Healthcare Pharmaceuticals INC. | $1,581.76 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,429.19 | 2019-2025 | Opdivo, Augtyro, Krazati |
| Merck Sharp & Dohme LLC | $1,294.12 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Genzyme Corporation | $1,148.65 | 2019-2025 | |
| Celgene Corporation | $1,117.02 | 2019-2025 | Reblozyl, Pomalyst, Opdivo |
| Sirtex Medical INC | $951.87 | 2020-2023 | Sir-Spheres Microspheres |
Show all 87 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $942.62 | 2019-2025 | |
| Amgen INC. | $808.68 | 2019-2023 | Lumakras |
| Astellas Pharma US INC | $746.31 | 2019-2025 | Xospata, Xtandi, Vyloy |
| Genentech USA, INC. | $739.04 | 2019-2025 | Polivy, Tecentriq, Venclexta |
| Daiichi Sankyo INC. | $725.53 | 2019-2025 | Enhertu, Datroway |
| Lilly USA, LLC | $603.95 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Tempus Ai, INC | $553.15 | 2024-2025 | Xt Cdx |
| Emd Serono, INC. | $480.95 | 2019-2025 | Bavencio |
| Abbvie INC. | $476.95 | 2019-2025 | Venclexta |
| Exelixis INC. | $476.75 | 2019-2025 | Cabometyx |
| Pharmacyclics LLC, An Abbvie Company | $414.01 | 2019-2023 | Imbruvica, Epkinly |
| Boehringer Ingelheim Pharmaceuticals, INC. | $409.48 | 2019-2025 | |
| Stemline Therapeutics INC. | $396.04 | 2022-2025 | Orserdu |
| Glaxosmithkline, LLC. | $378.81 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Regeneron Healthcare Solutions, INC. | $377.54 | 2019-2025 | Libtayo, Lynozyfic |
| Jazz Pharmaceuticals INC. | $348.20 | 2021-2025 | Zepzelca |
| Eisai INC. | $340.75 | 2019-2025 | |
| Novocure INC. | $277.00 | 2021-2025 | Optune Lua (Novottf-200t) |
| Alexion Pharmaceuticals, INC. | $276.72 | 2019-2024 | Ultomiris |
| Array Biopharma INC | $207.17 | 2019-2025 | Lorbrena, Braftovi, Mektovi |
| Ipsen Biopharmaceuticals, INC | $199.80 | 2019-2025 | Onivyde, Somatuline Depot |
| Aveo Pharmaceuticals, INC. | $199.57 | 2022-2025 | |
| G1 Therapeutics, INC. | $136.07 | 2022-2023 | Cosela |
| Adaptive Biotechnologies Corporation | $135.83 | 2022-2025 | Clonoseq |
| Advanced Accelerator Applications | $125.04 | 2019-2020 | |
| Kite Pharma, INC. | $122.50 | 2021-2025 | Yescarta |
| Karyopharm Therapeutics INC. | $100.88 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $100.54 | 2019-2025 | Rybrevant |
| Gilead Sciences, INC. | $99.24 | 2019-2024 | |
| Mirati Therapeutics, INC. | $93.77 | 2023-2024 | Krazati |
| Avyxa Pharma, LLC | $91.46 | 2025 | |
| Servier Pharmaceuticals LLC | $90.03 | 2023-2025 | |
| Kyowa Kirin, INC. | $87.59 | 2019-2022 | |
| Sobi, INC | $87.50 | 2022-2024 | |
| Rigel Pharmaceuticals, INC. | $86.90 | 2021-2024 | Tavalisse, Rezlidhia |
| Alnylam Pharmaceuticals INC. | $82.47 | 2019-2024 | Givlaari |
| Geron Corporation | $82.20 | 2025 | Rytelo |
| Deciphera Pharmaceuticals INC. | $81.63 | 2023-2025 | Qinlock, Romvimza |
| Tersera Therapeutics LLC | $76.96 | 2023-2025 | Zoladex |
| Medtronic, INC. | $76.59 | 2025 | Aurora Ev-Icd Mri Surescan |
| Adc Therapeutics America, INC. | $73.70 | 2023-2024 | |
| Caris Mpi, INC. | $73.47 | 2025 | Mi Cancer Seek |
| Taiho Oncology, INC. | $72.94 | 2019-2024 | |
| Legend Biotech USA INC. | $70.08 | 2024-2025 | Carvykti |
| Dova Pharmaceuticals | $66.19 | 2020-2021 | |
| Blueprint Medicines Corporation | $59.61 | 2021-2023 | Ayvakit |
| Verastem, INC. | $58.07 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $54.09 | 2024 | Sylvant |
| Pharmaessentia USA Corporation | $50.46 | 2024-2025 | Besremi |
| Octapharma USA, INC. | $49.31 | 2019-2023 | Panzyga |
| Mylan Institutional INC. | $39.54 | 2020-2022 | |
| Beone Medicines USA, INC. | $38.65 | 2025 | Brukinsa |
| Blue Earth Diagnostics | $37.73 | 2021-2024 | |
| Organon LLC | $37.67 | 2022 | |
| Sun Pharmaceutical Industries INC. | $37.27 | 2021-2025 | |
| Foundation Medicine, INC. | $37.15 | 2022-2023 | |
| Helsinn Therapeutics (U.S.), INC. | $35.33 | 2019 | |
| Morphosys, US INC. | $31.92 | 2021-2023 | Monjuvi |
| Aurobindo Pharma USA, INC. | $31.36 | 2019 | |
| Apellis Pharmaceuticals, INC. | $30.69 | 2024 | Empaveli |
| Intuitive Surgical, INC. | $29.02 | 2019 | |
| Amag Pharmaceuticals, INC. | $26.49 | 2019 | |
| Tolmar, INC. | $24.96 | 2023 | |
| Acrotech Biopharma INC. | $21.71 | 2024 | Ryzneuta |
| Boston Scientific Corporation | $20.86 | 2022 | |
| Fortovia Therapeutics, INC. | $19.79 | 2019 | |
| Ethicon INC. | $18.21 | 2020 | |
| Clovis Oncology, INC. | $18.15 | 2021 | |
| Accord Healthcare, INC. | $15.91 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $15.65 | 2021 | |
| Myovant Sciences INC. | $13.78 | 2021 | |
| Immunogen, INC. | $13.29 | 2023 | Elahere |
Drugs and devices associated with these payments
Imfinzi $3,496Brukinsa $3,433Tecvayli $2,020Monoferric $1,781Stivarga $1,272Keytruda $701Sir-Spheres Microspheres $565Xt Cdx $553Sarclisa $501Reblozyl $450Enhertu $436Darzalex $430Lynparza $380Jakafi $371Venclexta $312Imbruvica $305Opdivo $299Talvey $294Carvykti $287Ibrance $284Pluvicto $278Erleada $277Lenvima $257Cabometyx $256Xtandi $230Tukysa $230Tagrisso $226Elrexfio $219Pomalyst $206Bosulif $204Jaypirca $199Libtayo $193Talzenna $190Rybrevant $178Verzenio $162Ojjaara $162Adcetris $154Optune Lua (Novottf-200t) $152Orgovyx $150Kisqali $150Lorbrena $149Polivy $143Ultomiris $137Comirnaty $129Fruzaqla $127Braftovi $125Bavencio $124Tivdak $122Krazati $119Tecentriq $119Clonoseq $117Onivyde $117Padcev $113Paxlovid $111Welireg $110Mektovi $99.64Epkinly $98.68Nerlynx $97.09Augtyro $93.07Posfrea $91.46Docivyx $91.46Cyclophosphamide $91.46Axtle $91.46Inlyta $85.47Orserdu $84.40Rytelo $82.20Qinlock $81.63Alunbrig $81.38Ninlaro $80.42Zoladex $76.96Aurora Ev-Icd Mri Surescan $76.59Fotivda $74.80Mi Cancer Seek $73.47Ayvakit $73.44Rezlidhia $70.08Tavalisse $70.08Phesgo $69.88Zepzelca $69.62Tibsovo $69.21Yescarta $67.80Piqray $63.75Cablivi $61.56Xalkori $57.56Lutathera $57.30Zejula $54.85Besponsa $54.44Sylvant $54.09Inqovi $53.45Lonsurf $53.45Xospata $51.99Datroway $51.37Vitrakvi $51.33Vonjo $51.28Akeega $50.81Balversa $50.81Besremi $50.46Idhifa $48.38Eliquis $45.96Nubeqa $44.48Opdualag $42.64
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Humberto Caldera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.